Mark Woodhams - Dec 13, 2024 Form 4 Insider Report for BLACKLINE, INC. (BL)

Role: Chief Revenue Officer
Signature: /s/ Karole Morgan-Prager, Attorney-in-Fact
Stock symbol: BL
Transactions as of: Dec 13, 2024
Transactions value $: $71,322
Form type: 4
Date filed: 12/17/2024, 04:16 PM
Previous filing: Dec 16, 2024
Next filing: Feb 24, 2025

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BL	Common Stock	Options Exercise	$49.1K	+1K	+1.37%	$49.04	73.9K	Dec 13, 2024	Direct	F1
transaction	BL	Common Stock	Options Exercise	$22.2K	+456	+0.62%	$48.65	74.4K	Dec 13, 2024	Direct	F1

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BL	Stock Option (Right to Buy)	Options Exercise	$0	-456	-1.5%	$0.00	29.9K	Dec 13, 2024	Common Stock	456	$48.65	Direct	F1, F2
transaction	BL	Stock Option (Right to Buy)	Options Exercise	$0	-1K	-1.24%	$0.00	80.1K	Dec 13, 2024	Common Stock	1K	$49.04	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transaction reported on this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
F2	The options became exercisable based on the following vesting schedule, which shall be satisfied over a 5-year period: 25% of the shares subject to the option vested on the one (1) year anniversary of the grant date (the "Annual Option Vesting Commencement Date"), and 1/16th of the remaining options vest every three months thereafter on the same day of the month as the Annual Option Vesting Commencement Date, subject to the reporting person's continued service through each applicable vesting date.

Content

The transaction reported on this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.

The options became exercisable based on the following vesting schedule, which shall be satisfied over a 5-year period: 25% of the shares subject to the option vested on the one (1) year anniversary of the grant date (the "Annual Option Vesting Commencement Date"), and 1/16th of the remaining options vest every three months thereafter on the same day of the month as the Annual Option Vesting Commencement Date, subject to the reporting person's continued service through each applicable vesting date.